This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
AML1/ETO and its function as a regulator of gene transcription via epigenetic mechanisms
Oncogene Open Access 30 July 2021
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Peterson LF, Boyapati A, Ahn EY, Biggs JR, Okumura AJ, Lo MC et al. Acute myeloid leukemia with the 8q22;21q22 translocation: secondary mutational events and alternative t(8;21) transcripts. Blood 2007; 110: 799–805.
Yan M, Kanbe E, Peterson LF, Boyapati A, Miao Y, Wang Y et al. A previously unidentified alternatively spliced isoform of t(8;21) transcript promotes leukemogenesis. Nat Med 2006; 12: 945–949.
Era T, Asou N, Kunisada T, Yamasaki H, Asou H, Kamada N et al. Identification of two transcripts of AML1/ETO-fused gene in t(8;21) leukemic cells and expression of wild-type ETO gene in hematopoietic cells. Genes Chromosomes Cancer 1995; 13: 25–33.
Kozu T, Miyoshi H, Shimizu K, Maseki N, Kaneko Y, Asou H et al. Junctions of the AML1/MTG8(ETO) fusion are constant in t(8;21) acute myeloid leukemia detected by reverse transcription polymerase chain reaction. Blood 1993; 82: 1270–1276.
Ruiz A, Williams O, Brady HJ . The Ikaros splice isoform, Ikaros 6, immortalizes murine haematopoietic progenitor cells. Int J Cancer 2008; 123: 1240–1245.
Kwok C, Zeisig BB, Qiu J, Dong S, So CW . Transforming activity of AML1-ETO is independent of CBFbeta and ETO interaction but requires formation of homo-oligomeric complexes. Proc Natl Acad Sci USA 2009; 106: 2853–2858.
Park S, Chen W, Cierpicki T, Tonelli M, Cai X, Speck NA et al. Structure of the AML1-ETO eTAFH domain-HEB peptide complex and its contribution to AML1-ETO activity. Blood 2009; 113: 3558–3567.
Yan M, Ahn EY, Hiebert SW, Zhang DE . RUNX1/AML1 DNA-binding domain and ETO/MTG8 NHR2-dimerization domain are critical to AML1-ETO9a leukemogenesis. Blood 2009; 113: 883–886.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no conflict of interest.
Additional information
Supplementary Information accompanies the paper on the Leukemia website
Rights and permissions
About this article
Cite this article
Mannari, D., Gascoyne, D., Dunne, J. et al. A novel exon in AML1-ETO negatively influences the clonogenic potential of the t(8;21) in acute myeloid leukemia. Leukemia 24, 891–894 (2010). https://doi.org/10.1038/leu.2009.288
Published:
Issue Date:
DOI: https://doi.org/10.1038/leu.2009.288